Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000344060 | SCV000342287 | uncertain significance | not provided | 2016-05-17 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000764595 | SCV000895691 | uncertain significance | Pituitary hormone deficiency, combined, 2 | 2018-10-31 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000344060 | SCV001066531 | benign | not provided | 2024-01-25 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV000764595 | SCV001457808 | likely benign | Pituitary hormone deficiency, combined, 2 | 2020-04-24 | no assertion criteria provided | clinical testing | |
Prevention |
RCV004755846 | SCV005353018 | likely benign | PROP1-related disorder | 2024-04-03 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |